SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-143170
Filing Date
2019-05-09
Accepted
2019-05-09 17:15:56
Documents
3
Group Members
FROST GAMMA INVESTMENTS TRUSTPHILLIP FROST, M.D.

Document Format Files

Seq Description Document Type Size
1 SC 13D d745928dsc13d.htm SC 13D 115201
2 EX-99.1 d745928dex991.htm EX-99.1 6041
3 EX-99.2 d745928dex992.htm EX-99.2 4939
  Complete submission text file 0001193125-19-143170.txt   128356
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4138
Opko Health, Inc. (Filed by) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Subject) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-56243 | Film No.: 19811774
SIC: 8731 Services-Commercial Physical & Biological Research